Organovo shares are trading higher by 246% Tuesday morning. The company announced that Eli Lilly is set to acquire its FXR ...
Organovo today announced that Eli Lilly and Company (NYSE:LLY) ("Lilly") will acquire Organovo's FXR program, including its ...
Eli Lilly (NYSE: LLY) stock defied today's market downturn, rising 2.6% through 11:15 a.m. ET on the back of two positive ...
Real-time index price for S&P 500 Index (INX), along with buy or sell indicators, analysis, charts, historical performance, ...
SAN DIEGO (AP) — Organovo Holdings Inc. ONVO) on Wednesday reported a loss of $3.4 million in its fiscal third quarter. On a per-share basis, the San Diego-based company said it had a loss of 19 ...
Eli Lilly (LLY) on Tuesday launched higher doses of Zepbound, or tirzepatide, in single-dose vials and reduced the prices of two smaller doses of the weight-loss drug for self-pay patients. The ...
SAN DIEGO (AP) — SAN DIEGO (AP) — Organovo Holdings Inc. (ONVO) on Wednesday reported a loss of $3.4 million in its fiscal third quarter. On a per-share basis, the San Diego-based company said ...
Holdings announced that Eli Lilly (LLY) and Company will acquire Organovo’s FXR program, including its lead asset, FXR314.
Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary ...